CELL ADVANCED FUTURE AUTOMATION
Live / Registered — Registered (as of 20 Oct 2026)
What this means for you
Registered since 20 Oct 2026. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 20 Oct 2032: the §8 declaration of use).
Record
- Serial number
- 99400437
- Registration number
- 8516927
- Mark type
- Slogan / phrase
- Filed
- 18 Sept 2025
- Published for opposition
- 18 Nov 2025
- Registered
- 20 Oct 2026
- Next maintenance filing
- §8 declaration of use, due by 20 Oct 2032 (grace period to 20 Apr 2033)
- Attorney of record
- Christopher Bolinger
Goods and services
- Class 040 — Treatment of materials: Custom manufacture of pharmaceuticals
- Class 042 — Scientific and technological services: Testing, inspection or research of pharmaceuticals, cosmetics or foodstuff
- Class 044 — Medical, beauty and agricultural services: Providing medical information
Owner
- CELLAFA BIOSCIENCE INC., YUSHIMA, BUNKYO-KU, Tokyo, JP
- CELLAFA BIOSCIENCE INC., YUSHIMA, BUNKYO-KU, Tokyo, JP
- Astellas Pharma Inc., Tokyo, JP
- Astellas Pharma Inc., Tokyo, JP
Prosecution history
- 20 Oct 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 20 Oct 2026 — REGISTERED-PRINCIPAL REGISTER
- 29 Sept 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 29 Sept 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 30 Aug 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 06 Jul 2026 — USE AMENDMENT FILED
- 26 Aug 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 07 Jul 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 06 Jul 2026 — TEAS STATEMENT OF USE RECEIVED
- 06 Jul 2026 — SOU EXTENSION 1 GRANTED
- 06 Jul 2026 — SOU EXTENSION 1 FILED
- 06 Jul 2026 — SOU TEAS EXTENSION RECEIVED
- 29 Apr 2026 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 13 Jan 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 18 Nov 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED